- Details
- Description
Packaging Size:
30's (30 tablets per pack/container)
Strength:
100 mg
Composition:
Lorlatinib INN 100 mg
Treatment:
Oncology / anticancer
Form:
Tablet
Brand:
Lorbrexen
Quantity Unit:
30 tablets
Manufacturer:
Everest Pharmaceuticals Ltd.
Lorbrexen 100 (Lorlatinib INN 100 mg) is an oncology medicine manufactured by Everest Pharmaceuticals Ltd., Bangladesh. It contains Lorlatinib 100 mg, an oral targeted anticancer medicine. Lorlatinib is a tyrosine kinase inhibitor (TKI) that targets ALK and ROS1 signaling pathways involved in the growth and spread of certain cancer cells. It is used for the treatment of selected ALK-positive or ROS1-positive cancers, particularly certain forms of non-small cell lung cancer (NSCLC), according to the approved indication and physician's assessment. Everest officially lists Lorbrexen 100 under its Oncology products.
